Oral glucose tolerance testing to modulate plasma amyloid levels: A novel biomarker

INTRODUCTION: Plasma levels of amyloid-beta (Aβ) do not correlate well with different stages of Alzheimer's disease (AD) in cross-sectional studies. Measuring the changes in Aβ plasma levels with an acute intervention may be more sensitive to distinguishing individuals in earlier stages of AD (...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Esther S., Marano, Christopher M., Leoutsakos, Jeannie-Marie, Lee, Rebecca W., Rissman, Robert A., Smith, Gwenn S., Craft, Suzanne, Lyketsos, Constantine G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Blood-Based Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578701/
https://www.ncbi.nlm.nih.gov/pubmed/26413562
http://dx.doi.org/10.1016/j.dadm.2015.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578701/
https://www.ncbi.nlm.nih.gov/pubmed/26413562
http://dx.doi.org/10.1016/j.dadm.2015.06.002

Ejemplares similares